Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices 64915 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection 

Type of Collection: Reinstatement 

without change. 

OMB No.: 0990–0438. 

Abstract: The Office of Population 

Affairs (OPA), in the Office of the 

Assistant Secretary for Health (OASH), 

U.S. Department of Health and Human 

Services (HHS), requests clearance for 

the collection of performance measures 

specifically for FY2020 Teen Pregnancy 

Prevention (TPP) Program grantees. 

Collection of performance measures is a 

requirement of all TPP awards and is 

included in the NOFOs. The data 

collection will allow OPA to comply 

with federal accountability and 

performance requirements, inform 

stakeholders of grantee progress in 

meeting TPP program goals, provide 

OPA with metrics for monitoring TPP 

grantees, and facilitate individual 

grantees’ continuous quality 

improvement efforts within their 

projects. OPA requests clearance for one 

year to cover reporting during the nocost extension period of the awards. 

ESTIMATED ANNUALIZED BURDEN TABLE

Form Type of 

respondent 

Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Partners and sustainability ............... All TPP grantees .............................. 90 2 15/60 45 

Training ............................................. All TPP Grantees ............................. 90 2 15/60 45 

Dissemination ................................... All TPP Grantees ............................. 90 2 30/60 90 

Stakeholder Engagement ................. All TPP Grantees ............................. 90 2 15/60 45 

Reach and Demographics ................ Tier 1 and Tier 2 Phase II Grantees 64 2 3 384 

Dosage .............................................. Tier 1 and Tier 2 Phase II Grantees 64 2 2 256 

Fidelity and Quality ........................... Tier 1 and Tier 2 Phase II Grantees 64 2 2 256 

Tier 2 Innovation Network ................ Tier 2 Innovation Network Grantees 14 2 15/60 7 

Supportive Services (Tier 1) ............. Tier 1 Grantees ................................ 54 2 15/60 27 

Total ........................................... ........................................................... ........................ 2 ........................ 1155 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2023–20290 Filed 9–19–23; 8:45 am] 

BILLING CODE 4150–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Request for Public Comment: 30-Day 

Information Collection: Indian Health 

Service Forms To Implement the 

Privacy Rule 

AGENCY: Indian Health Service, HHS. 

ACTION: Notice and request for 

comments; request for extension of 

approval. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Indian Health Service (IHS) invites the 

general public to comment on the 

information collection titled, ‘‘IHS 

Forms to Implement the Privacy Rule’’ 

Office of Management and Budget 

(OMB) Control Number 0917–0030. This 

notice announces the IHS intent to 

submit the collection, which expires 

September 30, 2023, to OMB for 

approval of an extension with 

modifications, and to solicit comments 

on specific aspects of the information 

collection. 

DATES: Comment Due Date: October 20, 

2023. Your comments regarding this 

information collection are best assured 

of having full effect if received within 

30 days of the date of this publication. 

ADDRESSES: Send your comments and 

suggestions regarding the proposed 

information collection contained in this 

notice, especially regarding the 

estimated public burden and associated 

response time to: Office of Management 

and Budget, Office of Regulatory Affairs, 

New Executive Office Building, Room 

10235, Washington, DC 20503, 

Attention: Desk Officer for IHS. 

FOR FURTHER INFORMATION CONTACT: To 

request additional information, please 

contact Evonne Bennett, Information 

Collection Clearance Officer, by email: 

Evonne.Bennett@ihs.gov or (240) 472– 

1996. 

SUPPLEMENTARY INFORMATION: The IHS 

published a notice on this previously 

approved information collection in the 

Federal Register (88 FR 42726) on July 

3, 2023, and allowed 60 days for public 

comment. No public comment was 

received in response to the notice. The 

purpose of this notice is to allow 30 

days for public comment to be 

submitted to OMB. A copy of the 

supporting statement is available at 

www.regulations.gov (see Docket ID 

IHS_FRDOC_0001). 

Title of Collection: 0917–0030, IHS 

Forms to Implement the Privacy Rule 

(45 CFR parts 160 & 164). Type of 

Information Collection Request: 

Extension of the currently approved 

information collection, with 

modifications 0917–0030, IHS Forms to 

Implement the Privacy Rule (45 CFR 

parts 160 & 164). Form(s): IHS–810, 

IHS–912–1, IHS–912–2, IHS–913, IHS– 

917, IHS–982, and IHS–963. Need and 

Use of Information Collection: This 

collection of information is made 

necessary by the Department of Health 

and Human Services Rule entitled 

‘‘Standards for Privacy of Individually 

Identifiable Health Information’’ 

(Privacy Rule) (45 CFR parts 160 and 

164). The Privacy Rule implements the 

privacy requirements of the 

Administrative Simplification subtitle 

of the Health Insurance Portability and 

Accountability Act of 1996, creates 

national standards to protect an 

individual’s personal health 

information, and gives patients 

increased access to their medical 

records. 45 CFR 164.508, 164.520, 

164.522, 164.526 and 164.528 of the 

Rule require the collection of 

information to implement these 

protection standards and access 

requirements. The IHS will use the 


lotter on DSK11XQN23PROD with NOTICES1
64916 Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices 

following data collection instruments to 

meet the information collection 

requirements contained in the Rule. 

(a) 45 CFR 164.508—Authorization for 

Use or Disclosure of Protected Health 

Information (IHS–810) 

45 CFR 164.508 requires covered 

entities to obtain or receive a valid 

authorization for its use or disclosure of 

protected health information for 

purposes that are not otherwise 

authorized or required by HIPAA (e.g., 

treatment, payment and healthcare 

operations). Under this provision, 

individuals may initiate a written 

authorization permitting covered 

entities to release their protected health 

information to entities of their choosing. 

The form IHS–810 ‘‘Authorization for 

Use or Disclosure of Protected Health 

Information’’ is used by patients at IHS 

facilities to document and authorize the 

use, disclosure or release of their 

protected health information from their 

medical record to anyone they specify. 

(b) 45 CFR 164.522(a)(1)—Request For 

Restriction(s) (IHS–912–1) 

Under the Privacy Rule, an individual 

can request to restrict the use of their 

information with some exceptions. 

Section 164.522(a)(1) requires a covered 

entity to permit individuals to request 

that the covered entity restrict certain 

uses and disclosures of their protected 

health information. The covered entity 

may or may not agree to the restriction, 

and it is only required to agree in 

certain limited situations. The form 

IHS–912–1 ‘‘Request for Restrictions(s)’’ 

is used to document an individual’s 

request for restriction of their protected 

health information and whether IHS 

agreed or disagreed with the requested 

restriction. 

(c) 45 CFR 164.522(a)(2)—Request For 

Revocation of Restriction(s) (IHS–912– 

2) 

Section 164.522(a)(2) permits a 

covered entity to terminate its 

agreement to a restriction when the 

individual agrees to or requests the 

termination in writing. The form IHS– 

912–2 ‘‘Request for Revocation of 

Restriction(s)’’ is used to document the 

agency or individual request to 

terminate a formerly agreed to 

restriction regarding the use and 

disclosure of protected health 

information. A previous request to 

restrict information may be revoked by 

the individual or IHS, subject to the 

limitations set forth in 164.522(a)(2). 

(d) 45 CFR 164.528 and HHS Privacy 

Act Regulations, 45 CFR 5b.9(c)— 

Request for an Accounting of 

Disclosures (IHS–913) 

These provisions require the IHS, as 

a covered entity and an agency within 

HHS, to permit individuals to request 

that the IHS provide an accounting of 

disclosures of the individual’s protected 

health information and/or record. The 

form IHS–913 ‘‘Request for an 

Accounting of Disclosures’’ is used for 

the collection of information for the 

purpose of processing an accounting of 

disclosures requested by the patient 

and/or personal representative, and to 

document that request. 

(e) 45 CFR 164.526—Request for 

Correction/Amendment of Protected 

Health Information (IHS–917) 

This provision requires covered 

entities to permit an individual to 

request that the covered entity amend 

protected health information. If the 

covered entity accepts the requested 

amendment, in whole or in part, the 

covered entity must inform the 

individual that the request for an 

amendment is accepted. If the covered 

entity denies the requested amendment, 

in whole or in part, the covered entity 

must provide the individual with a 

written denial. The IHS developed the 

form (IHS–917) to permit individuals to 

submit their request and to document 

IHS’s acceptance or denial of a patient’s 

request to correct or amend their 

protected health information. 

(f) 45 CFR 164.520—Acknowledgement 

of Receipt of the IHS Notice of Privacy 

Practices (IHS–982) 

This provision requires covered 

entities to provide a Notice of Privacy 

Practices to patients and to document 

compliance with the notice 

requirements by retaining copies of 

written acknowledgments of the receipt 

of the notice or documentation of good 

faith efforts to obtain written 

acknowledgment. The IHS developed 

the form (IHS–982) to obtain the written 

acknowledgment of the receipt of the 

IHS Notice of Privacy Practices. 

(g) 45 CFR 164.522—Request for 

Confidential Communication by 

Alternative Means or Alternate 

Location (IHS–963) 

This provision requires covered 

entities to permit individuals to request 

and must accommodate reasonable 

requests by individuals to receive 

communications of protected health 

information from the covered health 

care provider by alternative means or at 

alterative locations. The IHS developed 

the form (IHS–963) to permit 

individuals to request communications 

by alternative means or locations. 

Completed forms used in this 

collection of information are filed in the 

IHS ‘‘Medical, Health and Billing 

Records,’’ a Privacy Act System of 

Records. Affected Public: Individuals 

and households. Type of Respondents: 

Individuals. Burden Hours: The table 

below provides the following details for 

this information collection: types of data 

collection instruments, estimated 

number of respondents, number of 

responses per respondent, average 

burden hour per response. 

TABLE—ESTIMATED ANNUAL BURDEN HOURS

Data collection instruments 

Estimated 

number of 

respondents 

Responses 

per 

respondent 

Average 

burden hour 

per response * 

Total annual 

burden hours 

‘‘Authorization for Use or Disclosure of Protected Health Information’’ (OMB 

No. 0917–0030, IHS–810) ........................................................................... 210,954 1 10/60 35,159 

‘‘Request for Restriction(s)’’ (OMB No. 0917–0030, IHS–912–1) ................... 214 1 10/60 36 

‘‘Request for Revocation of Restriction(s)’’ (OMB No. 0917–0030, IHS–912– 

2) .................................................................................................................. 3 1 10/60 .5 

‘‘Request for Accounting of Disclosures’’ (OMB No. 0917–0030, IHS–913) .. 39 1 10/60 6.5 

‘‘Request for Correction/Amendment of Protected Health Information’’ (OMB 

No. 0917–0030, IHS–917) ........................................................................... 54 1 10/60 9 

Acknowledgement of Receipt of the Notice of Privacy Practices Protected 

Health Information (IHS–982) ...................................................................... 39 1 10/60 6.5 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 181 / Wednesday, September 20, 2023 / Notices 64917 

TABLE—ESTIMATED ANNUAL BURDEN HOURS—Continued 

Data collection instruments 

Estimated 

number of 

respondents 

Responses 

per 

respondent 

Average 

burden hour 

per response * 

Total annual 

burden hours 

‘‘Request for Confidential Communication by Alternative Means or Alternate 

Location’’ No. 0917–0030 (IHS–963) ........................................................... 214 1 10/60 36 

Total Annual Burden ................................................................................. 211,303 ........................ ........................ 35,253.5 

* For ease of understanding, burden hours are provided in actual minutes. 

The total estimated burden for this 

collection of information is 35,253.5 

hours. 

There are no capital costs, operating 

costs and/or maintenance costs to 

respondents to report. 

Requests for Comments: Your written 

comments and/or suggestions are 

invited on one or more of the following 

points: 

(a) Whether the information collection 

activity is necessary to carry out an 

agency function; 

(b) Whether the agency processes the 

information collected in a useful and 

timely fashion; 

(c) The accuracy of the public burden 

estimate (the estimated amount of time 

needed for individual respondents to 

provide the requested information); 

(d) Whether the methodology and 

assumptions used to determine the 

estimates are logical; 

(e) Ways to enhance the quality, 

utility, and clarity of the information 

being collected; and 

(f) ways to minimize the public 

burden through the use of automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Roselyn Tso, 

Director, Health Service. 

[FR Doc. 2023–20329 Filed 9–19–23; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: October 24, 2023. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G13, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Mairi Noverr, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G13, Rockville, MD 

20852, (240) 747–7530, mairi.noverr@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 14, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20326 Filed 9–19–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders C Study Section Translational 

Neural, Brain, and Pain Relief Devices (NSD– 

C). 

Date: October 17–18, 2023. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Canopy by Hilton, 940 Rose Avenue, 

North Bethesda, MD 20852. 

Contact Person: Ana Olariu, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Rockville, MD 20852, 301–496–9223, 

ana.olariu@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group; Neurological Sciences and 

Disorders B Study Section. 

Date: October 19–20, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Intercontinental San Francisco, 888 

Howard Street, San Francisco, CA 94103. 

Contact Person: Joel A. Saydoff, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Rockville, MD 20852, 301–496–9223, 

joel.saydoff@nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel; BRAIN Initiative: Research 

Resource Grants for Technology Integration 

and Dissemination (U24 Clinical Trial Not 

Allowed). 

Date: October 26, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852 (Virtual 

Meeting). 

Contact Person: Bo-Shiun Chen, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

NINDS/NIH, NSC, 6001 Executive Blvd., 

Rockville, MD 20852, 301–496–9223, boshiun.chen@nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1